← Back to Search

Behavioural Intervention

Galvanic Vestibular Stimulation for Healthy Subjects

N/A
Waitlist Available
Led By Gaurav N Pradhan, PhD
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up during the rotation of the chair, approximately 1 hr
Awards & highlights

Study Summary

This trial is testing a new medicine for motion sickness, and how it affects people's ability to do physical tasks.

Eligible Conditions
  • Healthy Subjects

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~during the rotation of the chair, approximately 1 hr
This trial's timeline: 3 weeks for screening, Varies for treatment, and during the rotation of the chair, approximately 1 hr for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Motion Perception
Secondary outcome measures
Motion Sickness Questionnaire

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Galvanic Vestibular Stimulation Starting From Mid-sessionExperimental Treatment1 Intervention
Subjects given Galvanic Vestibular Stimulation (GVS) to mitigate motion sickness in the rotating chair turning stimulation ON from the middle of the session.
Group II: Galvanic Vestibular Stimulation During the Entire SessionExperimental Treatment1 Intervention
Subjects given Galvanic Vestibular Stimulation (GVS) to mitigate motion sickness in the rotating chair turning stimulation ON from beginning.
Group III: No Galvanic Vestibular StimulationActive Control1 Intervention
Subjects were not given Galvanic Vestibular Stimulation (GVS) to mitigate motion sickness in the rotating chair turning stimulation entire session.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Galvanic Vestibular Stimulation
2021
N/A
~70

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor
3,209 Previous Clinical Trials
3,767,121 Total Patients Enrolled
Gaurav N Pradhan, PhDPrincipal InvestigatorMayo Clinic

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Non-pharmaceutical Motion Sickness Mitigation
Gaurav N. Pradhan 2021. "Non-pharmaceutical Motion Sickness Mitigation". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04859868.
~7 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top